Is ezetimibe safe in pregnancy?
Ezetimibe (Zetia) is pregnancy category C. Animal studies show no direct fetal harm, but inadequate human data exists, so use only if benefits outweigh risks. It crosses the placenta in animals, with unclear effects on fetal cholesterol levels.[1]
Is Vascepa safe in pregnancy?
Vascepa (icosapent ethyl) lacks formal pregnancy category due to limited data. It contains EPA omega-3 fatty acids, generally considered safe from dietary sources, but high-dose prescription forms have no controlled trials. Animal studies at high doses showed no teratogenicity, but human pregnancy outcomes are unknown. Avoid unless essential.[2][3]
Any interaction between ezetimibe and Vascepa in pregnancy?
No specific pharmacokinetic interactions reported between ezetimibe and Vascepa. Ezetimibe inhibits intestinal cholesterol absorption; Vascepa lowers triglycerides via PPAR activation. They are sometimes combined for mixed dyslipidemia without noted synergy or antagonism. Pregnancy status does not alter this—concerns stem from individual drug profiles, not combo effects.[4]
Should you avoid this combination in pregnancy?
Yes, avoid both individually and together unless clearly needed, per standard lipid management guidelines. Statins are first-line but contraindicated; ezetimibe or fibrates like Vascepa serve as alternatives in select cases, but non-drug options (diet, exercise) are preferred. Consult OB-GYN and cardiologist; monitor lipids without meds if possible. No dedicated studies on the pair in pregnancy exist.[5]
Alternatives for high cholesterol/triglycerides during pregnancy
- Lifestyle: Low-fat diet, omega-3-rich foods (fish oil supplements at <3g/day may be okay).
- Safe meds: Limited—bile acid sequestrants (e.g., cholestyramine) are category B.
- Postpartum: Restart ezetimibe/Vascepa if indicated, as lactation data is also sparse.
[1] Zetia (ezetimibe) prescribing information, Merck.
[2] Vascepa (icosapent ethyl) prescribing information, Amarin.
[3] FDA Pregnancy and Lactation Labeling Rule summaries, Drugs.com.
[4] Clinical Pharmacology & Therapeutics, ezetimibe-omega-3 combo studies.
[5] ACOG guidelines on dyslipidemia in pregnancy, 2022.